2025 annual financial data
ARS Pharmaceuticals 2025 Net margin
Direct answer
Net margin was -203.25%.
Operating income was -179,448,000 USD and net income was -171,298,000 USD.
Operating cash flow was -170,866,000 USD.
Get free ARS Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 84,278,000 USD
- Operating income
- -179,448,000 USD
- Net income
- -171,298,000 USD
- Operating cash flow
- -170,866,000 USD